In RSL Revival Season 4 playoffs lower bracket round 1, Protoss player Zoun faces Terran Cure in a high-stakes BO5 survival match after both dropped from upper bracket quarterfinals last week—Zoun swept 0-3 by Maru and Cure falling 2-3 in a thriller to ByuN. Zoun advanced as Group A runner-up with solid 2-1 record, while Cure topped Group C undefeated in matches, reflecting trader consensus on their seeding. Zoun leads head-to-head 7-4 across 11 prior meetings, including a 4-3 lower bracket upset over Cure in last year's playoffs, but Cure enters hotter with 3-of-5 recent match wins versus Zoun's 2-of-5. PvT map pool favors Protoss on several venues like Old Republic LE, amid stable LotV meta emphasizing macro execution and adaptation in double-elimination format.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedZoun vs Cure
This market will resolve to "Zoun" if Zoun win the match against Cure.
This market will resolve to "Cure" if Cure win the match against Zoun.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
Market Opened: Mar 27, 2026, 3:50 AM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Zoun vs Cure
This market will resolve to "Zoun" if Zoun win the match against Cure.
This market will resolve to "Cure" if Cure win the match against Zoun.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
Market Opened: Mar 27, 2026, 3:50 AM ET
Resolution Source
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...In RSL Revival Season 4 playoffs lower bracket round 1, Protoss player Zoun faces Terran Cure in a high-stakes BO5 survival match after both dropped from upper bracket quarterfinals last week—Zoun swept 0-3 by Maru and Cure falling 2-3 in a thriller to ByuN. Zoun advanced as Group A runner-up with solid 2-1 record, while Cure topped Group C undefeated in matches, reflecting trader consensus on their seeding. Zoun leads head-to-head 7-4 across 11 prior meetings, including a 4-3 lower bracket upset over Cure in last year's playoffs, but Cure enters hotter with 3-of-5 recent match wins versus Zoun's 2-of-5. PvT map pool favors Protoss on several venues like Old Republic LE, amid stable LotV meta emphasizing macro execution and adaptation in double-elimination format.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated

Beware of external links.
Beware of external links.
Frequently Asked Questions